Search results
Dr Himanshu Brahmbhatt Co-Founder and Joint-CEO. Co-founded EnGeneIC Pty Ltd in 2001 and built it from the concept stage to a company based in Australia and USA, a small scale manufacturing plant in Sydney and now a clinical stage biopharmaceutical company.
Jan 31, 2022 · Australian biotechnology company EnGeneIC has cancer and COVID-19 squarely in its sights. Armed with world-first cyto-immunotherapy, Co-Founders and Joint CEOs Jennifer MacDiarmid and Himanshu Brahmbhatt believe effective treatment may be closer than ever.
Himanshu Brahmbhatt. Co-Founder, Joint-CEO & Director. View in org chart. Himanshu graduated with an M.Sc. from the MS University (Baroda, India) and Ph.D from University of Adelaide (Australia).
- Co-Founder, Joint-CEO & Director
- Engeneic, Engeneic
Oct 2, 2011 · Four years ago, Dr Jennifer MacDiarmid and Dr Himanshu Brahmbhatt sparked worldwide interest with a revolutionary new technique to deliver chemotherapy.
Himanshu Brahmbhatt is known for Rog (2005), Vishwasghaat (1996) and Dil Hai Ki Manta Nahin (1991).
- Himanshu Brahmbhatt
Nov 30, 2021 · EngeneIC joint Chief Executive, Dr Himanshu Brahmbhatt, believes it will be effective. "These high-affinity antibodies are capable of locking on in such a way that it hangs on — no matter what ...
Joint CEOs, Dr Himanshu Brahmbhatt and Dr Jennifer MacDiarmid, described it as a “meet-ing of minds”. “We believe this collaboration will result in an effective vaccine, particularly against mutants of concern, being deployed in developing countries where vaccine rollout is logistically challenging,” Dr Brahmbhatt said.
